Landcadia Holdings IV, Inc. LCA
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 142.91M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.23
- Inst. own
- 81.93%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.50
- 200-d avg
- 10.36
- 1y target
- 0.00
News
3 months ago globenewswire.com
Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease
Topline six-month efficacy data expected by end of 2027 Phase 3 study follows FDA alignment on registrational trial design through Rare Disease Evidence Principles (RDEP) program Opus Genetics may…
3 months ago globenewswire.com
Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease
Successful Type B RDEP Meeting confirms FDA alignment on pivotal Phase 3 study design FDA indicates Opus Genetics may submit a BLA based on 6-month efficacy data, with 12-month durability data…
4 months ago gurufocus.com
Vontier Surpasses 2030 Emissions Target Five Years Early, Sets New 65% Reduction Goal
Vontier (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, today released its 2
6 months ago globenewswire.com
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
RESEARCH TRIANGLE PARK, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene…
8 months ago seekingalpha.com
Opus Genetics: Asymmetric Upside With LCA5 And BEST1
Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Its lead candidate is OPGx-LCA5, which is moving into Phase 3 enrollment. Interestingly, OPGx-LCA5's Phase 1/2…
10 months ago globenewswire.com
Beyond Meat® Releases 2024 Corporate Responsibility Report and LCA Study that Estimates Environmental Benefits of Beyond Burger® IV, Submits to CDP for First Time
EL SEGUNDO, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- With a mission to positively impact human health, climate change, constraints on natural resources and animal welfare, Beyond Meat, Inc. (NASDAQ:…
12 months ago globenewswire.com
Opus Genetics Announces Successful FDA Meeting Supporting Advancement of OPGx-LCA5 Toward Pivotal Trial for LCA5-Related Inherited Retinal Disease
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of OPGx-LCA5 First participant enrolled in run-in period for…
1 year ago globenewswire.com
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting toxicities Lasting, durable responses…
1 year ago globenewswire.com
Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of…
1 year ago globenewswire.com
Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
Improvements in subjective and objective measures of efficacy observed at six months persisted for one year in patients with severe vision impairment from inherited retinal degeneration due to…
1 year ago globenewswire.com
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is…
1 year ago globenewswire.com
Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
New Data from First Three Adult Patients in Phase 1/2 Trial with OPGx-LCA5 Showed that Subjective and Objective Signs of Efficacy Persisted for One Year New Data from First Three Adult Patients in…
1 year ago globenewswire.com
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025 New 12-month data on the first three adult OPGx-LCA5 patients to be…
1 year ago globenewswire.com
Beyond Meat® Releases 2023 ESG Report and LCA Study that Estimates Environmental Benefits of Beyond Steak® Plant-Based Seared Tips When Compared to Pre-Cooked Beef-Based Steak Tips
EL SEGUNDO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- With a mission to positively impact human health, climate change, constraints on natural resources and animal welfare, Beyond Meat, Inc. (NASDAQ:…
3 years ago headlinesoftoday.com
Segway-Ninebot Goes Green with Electric KickScooters and More Sustainable Practices
BEIJING, July 3, 2023 /PRNewswire/ — Segway-Ninebot, a global enterprise in the field of intelligent short-distance transportation and service robots, has received the world’s first Life Cycle…
4 years ago headlinesoftoday.com
Last Chance for Animals, Animal Liberation Wave Undercover Investigation Unveils More Atrocities in South Korean Dog Meat Trade
SEOUL, South Korea and LOS ANGELES, Aug. 14, 2022 /PRNewswire/ – A new, five-month undercover investigation by Los Angeles-based Last Chance for Animals (LCA) and Seoul-based Animal Liberation Wave…
4 years ago headlinesoftoday.com
Life Cycle Assessment (LCA) Study in India Shows that Aluminium Beverage Cans have Superior Environmental Performance over Glass, PET and Multi-layer Drinks Containers
A recent study by The Energy and Resources Institute (TERI), a first-of-its-kind in India, comparing the most used beverage packaging substrates, sh...
5 years ago seekingalpha.com
Landcadia Holdings III, Inc. (LCY) CEO Doug Cahill on Q1 2021 Results - Earnings Call Transcript
Landcadia Holdings III, Inc. (LCY) CEO Doug Cahill on Q1 2021 Results - Earnings Call Transcript
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Landcadia Holdings III, Inc. - LCY
NEW YORK, Feb. 5, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class…
5 years ago investorplace.com
A Smooth Transition Is Great News For Landcadia Holdings II
Concerns over delays in the merger vote were overblown. With that out of the way, let's look to the future of LCA and GNOG stock.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
This morning 301 companies reached new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 172 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 243 stocks hit new 52-week highs.
-
5 years ago benzinga.com
77 Biggest Movers From Friday
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares surged 93.2% to close at $34.78 on Friday after the company priced its IPO at $18 per share.
-
5 years ago benzinga.com
12 Financial Services Stocks Moving In Thursday's Intraday Session
12 Financial Services Stocks Moving In Thursday's Intraday Session
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
On Monday morning, 181 companies achieved new highs for the year. Points of Interest: Tesla (NASDAQ: TSLA) was the biggest firm by market cap to hit a new 52-week high.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
This morning 230 companies reached new 52-week highs.
-
6 years ago benzinga.com
12 Financial Services Stocks Moving In Monday's Pre-Market Session
Gainers • SuRo Capital, Inc. (NASDAQ:SSSS) stock moved upwards by 32.82% to $12.99 during Monday's pre-market session. The most recent rating by BTIG, on Jul 8, is at Buy, with a price target of $12.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, October 3rd
Stocks Which Set New 52-Week High Yesterday, October 3rd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, October 2nd
Stocks Which Set New 52-Week High Yesterday, October 2nd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week High Yesterday, October 1st
Stocks Which Set New 52-Week High Yesterday, October 1st